Mirum Pharmaceuticals Inc (NASDAQ: MIRM) started the day on Wednesday, with a price increase of 3.88% at $43.92, before settling in for the price of $42.28 at the close. Taking a more long-term approach, MIRM posted a 52-week range of $23.14-$45.81.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 88.90% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -39.57%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 56.36%. This publicly-traded company’s shares outstanding now amounts to $46.72 million, simultaneously with a float of $38.04 million. The organization now has a market capitalization sitting at $2.10 billion. At the time of writing, stock’s 50-day Moving Average stood at $39.96, while the 200-day Moving Average is $33.07.
Mirum Pharmaceuticals Inc (MIRM) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Mirum Pharmaceuticals Inc’s current insider ownership accounts for 20.26%, in contrast to 93.80% institutional ownership. According to the most recent insider trade that took place on Sep 18 ’24, this organization’s Director bought 115 shares at the rate of 37.40, making the entire transaction reach 4,301 in total value, affecting insider ownership by 162,308. Preceding that transaction, on Sep 06 ’24, Company’s Director bought 230 for 41.58, making the whole transaction’s value amount to 9,563. This particular insider is now the holder of 162,193 in total.
Mirum Pharmaceuticals Inc (MIRM) Earnings and Revenue Records
Mirum Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 56.36% and is forecasted to reach -0.85 in the upcoming year.
Mirum Pharmaceuticals Inc (NASDAQ: MIRM) Trading Performance Indicators
Let’s observe the current performance indicators for Mirum Pharmaceuticals Inc (MIRM). It’s Quick Ratio in the last reported quarter now stands at 3.15. The Stock has managed to achieve an average true range (ATR) of 1.76. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.82.
In the same vein, MIRM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.07, a figure that is expected to reach -0.31 in the next quarter, and analysts are predicting that it will be -0.85 at the market close of one year from today.
Technical Analysis of Mirum Pharmaceuticals Inc (MIRM)
If we take a close look at the recent performances of Mirum Pharmaceuticals Inc (NASDAQ: MIRM), its last 5-days Average volume was 0.45 million that shows plunge from its year to date volume of 0.56 million. During the previous 9 days, stock’s Stochastic %D was recorded 68.10% While, its Average True Range was 1.90.
Raw Stochastic average of Mirum Pharmaceuticals Inc (MIRM) in the period of the previous 100 days is set at 85.96%, which indicates a major rise in contrast to 75.28% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 29.26% that was lower than 44.38% volatility it exhibited in the past 100-days period.
